ArticleFrontiers in immunology2023

Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer.

Yuchen Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.